TRANCYP Tablet by Dr Precision is a pharmaceutical-grade antidepressant containing Tranylcypromine, a potent monoamine oxidase inhibitor (MAOI) specifically formulated to treat major depressive disorder (MDD) and atypical depression cases resistant to conventional antidepressants such as SSRIs and SNRIs. Manufactured by BluepillExpress under rigorous GMP-certified, WHO-GMP, ISO, and Schedule M guidelines, TRANCYP ensures high purity, bioavailability, and efficacy. It operates by irreversibly inhibiting MAO-A and MAO-B enzymes, thereby elevating brain neurotransmitters serotonin, norepinephrine, and dopamine, effectively alleviating depressive symptoms unresponsive to first and second-line therapies. TRANCYP is ideal for psychiatric use in treatment-resistant depression, refractory mood disorders, and suicidal ideation related to depression under strict clinical supervision. The product is available in moisture-resistant packaging formats with comprehensive quality checks, validated potency, and is backed by a Certificate of Analysis (COA). TRANCYP carries detailed safety guidelines including dietary restrictions to avoid hypertensive crises, making it a reliable, clinically-approved choice in complex depression management in regulated international markets.
Key Features
| Features | Description |
|---|---|
| Active Ingredient | Tranylcypromine - a non-hydrazine monoamine oxidase inhibitor (MAOI) |
| Indication | Treatment-resistant Major Depressive Disorder, Atypical Depression, Suicidal ideation with depression |
| Manufacturer | BluepillExpress under Dr Precision brand |
| Quality Standards | WHO-GMP, ISO, Schedule M compliant manufacturing facility |
| Pharmacological Action | Irreversible inhibition of MAO-A and MAO-B enzymes increasing serotonin, norepinephrine, dopamine |
| Dosage Form | Oral Tablet |
| Packaging | Moisture-resistant aluminum blister strips or HDPE bottles with tamper-proof seals |
| Special Handling | Requires dietary restrictions to avoid tyramine-containing foods to prevent hypertensive crises |
| Quality Control | Validated HPLC testing, dissolution, hardness, friability, microbial contamination checks |
| Export Compliance | Certificate of Analysis and regulatory documentation included for export |
| Attributes | Description |
|---|---|
| Active Pharmaceutical Ingredient (API) | Tranylcypromine |
| Tablet Strength | Per market requirement (typically 10 mg or 20 mg) |
| Therapeutic Class | Monoamine Oxidase Inhibitor (MAOI) |
| Shelf Life | As per regulatory approval and packaging |
| Storage Instructions | Store in a cool, dry place away from direct sunlight |
| Route of Administration | Oral |
| Dosage Recommendations | Once or twice daily dosing as per clinician assessment |
| Packaging Options | Aluminum blister strips and HDPE bottles |
| Regulatory Compliance | Manufactured under GMP, WHO-GMP, ISO, Schedule M |
| Safety Information | Comprehensive patient inserts with dietary and pharmacologic guidance |
*Disclaimer: The above description has been AI-generated and has not been audited or verified for accuracy. It is recommended to verify product details independently before making any purchasing decisions.
TRANCYP Tablet is specially formulated for major depressive disorder, atypical depression characterized by hypersomnia and increased appetite, and treatment-resistant depression cases unresponsive to SSRIs, SNRIs, and tricyclic antidepressants.
Unlike SSRIs or SNRIs, TRANCYP contains Tranylcypromine, an irreversible MAOI that inhibits both MAO-A and MAO-B enzymes, increasing multiple neurotransmitters' levels by preventing their breakdown, thus targeting refractory depression effectively.
Clinical supervision is critical to monitor potential side effects like hypertensive crises. Patients must adhere to dietary restrictions avoiding tyramine-rich foods and comply with washout periods when switching from or to other antidepressants.
Each batch undergoes rigorous HPLC validation for active ingredient quantification, dissolution, hardness and friability testing, microbial contamination screening, and packaging integrity checks, aligned with WHO-GMP, ISO, and Schedule M standards.
Yes, BluepillExpress offers moisture-resistant aluminum blister strips and HDPE bottles with tamper-proof seals, along with customized labeling and complete regulatory documentation including Certificates of Analysis for international shipments.
No, patients must avoid tyramine-rich foods such as aged cheeses, fermented products, and certain wines while on TRANCYP to prevent hypertensive crises due to its MAOI activity.
Country Of Origin: India
TRANCYP Tablet contains Tranylcypromine, a monoamine oxidase inhibitor (MAOI) used in the treatment of major depressive disorder, especially in cases resistant to other antidepressants. Manufactured by BluepillExpress under stringent third-party GMP-certified standards, this medication is formulated for optimal efficacy in restoring mood and emotional balance in treatment-resistant depression.
This product is manufactured under the Dr Precision label, ensuring GMP-compliant quality and precision formulation standards.
TRANCYP Tablet is a potent antidepressant formulation developed by BluepillExpress containing Tranylcypromine, a non-hydrazine monoamine oxidase inhibitor (MAOI) known for its effectiveness in treatment-resistant depression, atypical depression, and major depressive episodes that have not responded to first-line therapies such as SSRIs or SNRIs.
As a third-party manufacturer of global pharmaceutical standards, BluepillExpress ensures that every TRANCYP Tablet is manufactured in compliance with WHO-GMP, ISO, and Schedule M guidelines. The facility utilizes state-of-the-art technology to perform precision blending, compression, and coating, ensuring each tablet meets rigorous pharmaceutical-grade purity, stability, and bioavailability requirements.
Pharmacologically, Tranylcypromine works by irreversibly inhibiting the activity of monoamine oxidase enzymes (MAO-A and MAO-B), which are responsible for the breakdown of key neurotransmitters such as serotonin, norepinephrine, and dopamine. By preventing their breakdown, TRANCYP increases the availability of these mood-elevating chemicals in the brain, thereby alleviating symptoms of deep-seated and chronic depression.
Indications for TRANCYP Tablet include:
Major Depressive Disorder (MDD)
Atypical depression with features like hypersomnia and increased appetite
Depression with suicidal ideation, especially when refractory to other treatments
Persistent mood disorders unresponsive to SSRIs, tricyclics, or SNRIs
One of the key strengths of TRANCYP is its ability to bring therapeutic relief in patients who have failed to benefit from two or more classes of antidepressants. It is often prescribed by psychiatrists in specialized settings, with careful dietary and pharmacologic supervision to mitigate potential interactions.
TRANCYP is best administered once or twice daily, depending on clinical assessment. Patients on this medication require dietary restrictions to avoid tyramine-containing foods such as aged cheeses, fermented products, and certain wines, due to the risk of hypertensive crisis. BluepillExpress includes all safety and dosage guidelines in its packaging and patient inserts to ensure informed use.
Though highly effective, TRANCYP must be initiated and discontinued cautiously. Washout periods are mandatory when switching from or to other antidepressant classes. Clinical monitoring is advised for the first few weeks to observe for improvements in mood and to watch for side effects such as insomnia, dizziness, dry mouth, or hypertensive responses.
Each batch of TRANCYP Tablet is:
Subjected to validated HPLC testing for active ingredient quantification
Evaluated for dissolution rate, hardness, friability, and disintegration
Quality-checked for microbial contamination, uniformity of content, and packaging integrity
Export-compliant and accompanied by a Certificate of Analysis (COA) and all necessary regulatory documentation
BluepillExpress also offers customized packaging and labeling for international clients, making TRANCYP a widely accepted export product in regulated markets across Asia, Africa, Latin America, and Eastern Europe.
TRANCYP is presented in moisture-resistant aluminum blister strips or HDPE bottles with tamper-proof seals to preserve its potency and shelf life. BluepillExpress upholds a commitment to clinical safety and therapeutic efficacy, making TRANCYP a reliable choice in the psychiatric healthcare domain.
In today’s mental health landscape, where resistant depression is increasingly diagnosed, TRANCYP from BluepillExpress fills a critical therapeutic gap—offering hope, relief, and recovery to patients who have struggled for far too long.
Inclusive of all taxes
You Save: 0
Surat , India
Manufacturer, Contractor, Retailer, Brand Owner, Distributor, Exporter, Importer, Wholesaler, Startup
GST- 24abdfb4194j1ze
